about
protein kinase activityphosphatidylinositol 3-kinase activitymevalonate kinase activitydiacylglycerol kinase activityD-erythro-sphingosine kinase activityNAD+ kinase activitydephospho-CoA kinase activityglycerol kinase activitycholine kinase activityethanolamine kinase activitygluconokinase activityacylglycerol kinase activityfructosamine-3-kinase activityfucokinase activitylipid kinase activitycreatine kinase activitypantothenate kinase activityglucose-1,6-bisphosphate synthase activitycarbohydrate kinase activityphosphatidylinositol phosphate kinase activityselenide, water dikinase activityadenylylsulfate kinase activityglycerone kinase activitytriokinase activityADP-specific glucokinase activityribosylnicotinamide kinase activityphosphoglycerate kinase activityinositol-1,3,4,5,6-pentakisphosphate kinase activitydiphosphoinositol-pentakisphosphate kinase activityriboflavin kinase activitynucleobase-containing compound kinase activityglycerate kinase activitydolichol kinase activitypyridoxal kinase activitysedoheptulokinase activity4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activityshikimate kinase activitytetraacyldisaccharide 4'-kinase activityinositol pentakisphosphate 2-kinase activityhydroxylysine kinase activity
P279
Cyclin dependent kinase 1Integrin linked kinaseATM serine/threonine kinaseGlucokinaseInsulin receptorPyruvate dehydrogenase kinase, isoenzyme 1Ataxia telangiectasia mutatedC-abl oncogene 1, non-receptor tyrosine kinaseMechanistic target of rapamycin kinaseErb-b2 receptor tyrosine kinase 2Lymphocyte protein tyrosine kinasePhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alphaPhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit deltaNeurotrophic tyrosine kinase, receptor, type 1Neurotrophic tyrosine kinase, receptor, type 2Neurotrophic tyrosine kinase, receptor, type 3Insulin-like growth factor I receptorV-raf-leukemia viral oncogene 1Bone morphogenetic protein receptor, type 1AActivin A receptor, type ICActivin A receptor, type 1BActivin A receptor, type 1Activin receptor IIAActivin receptor IIBEukaryotic translation initiation factor 2-alpha kinase 2Bruton agammaglobulinemia tyrosine kinaseAurora kinase AMitogen-activated protein kinase 9Zeta-chain (TCR) associated protein kinaseSpleen tyrosine kinaseCyclin-dependent kinase-like 5Transforming growth factor, beta receptor ITransforming growth factor, beta receptor IIFibroblast growth factor receptor 2Aurora kinase BCyclin-dependent kinase 2Cyclin-dependent kinase 4Cyclin-dependent kinase 6IL2 inducible T cell kinaseCheckpoint kinase 2
P680
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomasPACE-1, a novel protein that interacts with the C-terminal domain of ezrinMutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stabilitySKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxiaCDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndromeNek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: in vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activityThe novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteinsTranscription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2Ligand interaction scan (LIScan) in the study of ERK8.Regulation of the activity and expression of ERK8 by DNA damage.Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations.
P921
Q14820641-50F69D97-41DD-4901-A756-5E706A2721A7Q14887667-CE741B08-EB75-4916-82E0-116BCD8C5807Q14913009-44F65E78-AD0D-4F40-BF5C-CE0AF0A80F31Q14913817-BDF32CA8-3434-4C79-82A4-41DF0C528466Q14913819-C56288C9-1711-405E-A97C-03B8D6E10A44Q15321383-E8AFFED3-EAC0-4D6A-BF84-D3587F628ABBQ21101034-70C35E50-A2E0-4296-8808-64DD1F110F36Q21101627-11B5A466-11D3-44AD-860F-816FB2BE4FC1Q21102316-AF61F03B-F112-44B7-8D56-4F41B160C595Q21102317-916DB3D4-6AEB-4A8F-AF17-DB29AC51A4CFQ21103252-C11EA231-6869-46CB-B96F-A9AFDD2F47E5Q21104996-3BDF451E-C8F2-40A5-BC9E-B1D7B13957B4Q21107345-B57BAC03-184D-43F7-ABBD-A55DDB779A48Q21107516-B9E43452-08BE-4013-BF94-8AD7AC067274Q21110080-CB5152C3-77E8-4FEE-B03B-8C0623A9BC3EQ21111599-257A1020-0011-4343-B306-824F7B744BC3Q21117660-55B631BC-AF35-4558-A65B-E67791D789D9Q21120440-429703AA-4925-4CE2-A1C7-38CF3801B729Q21121417-D4C0AF25-A898-4807-9E32-8B449287F72AQ21121802-D46C31AB-3F94-4BB5-AACF-1AF997BF7C3CQ21122099-98D4AE15-C097-47B0-B67B-A54C80D09D0BQ21123694-6C0FB9EF-FE22-48D6-B05F-4DBEA9F1435AQ21127168-1DC63B8B-DD4C-49C8-AE48-A94138A38AE8Q21127169-78147BC5-0D1B-4B64-AC70-BD1361B5101FQ21132087-9BAEB27B-5540-48EB-9BD7-01C8D5016AACQ21132317-A5FA5787-EE3E-4D47-821F-E0192647C1C3Q21134371-FBCBE983-BC11-49E6-B594-698C1A798F2AQ21135898-5E81D75F-F835-402B-B5AA-E8C510E4E5DCQ21135902-9B5FD940-939A-40A0-8D7F-13CFD8475FD0Q21136982-D263387C-4B5A-4AFD-A437-3ED1C6192B87Q21138857-35249D07-6701-4AD6-B41E-6F777B6CC1BFQ21173295-89FFED87-509E-453E-9C2D-48CA9101D33AQ21173705-08894525-BF42-4B7C-854E-6FBEF3338704Q21174143-5C54A91F-D465-4F39-90AF-235783F61589Q21174239-00F1D21E-1F07-412E-847A-35E78012A9C0Q21198648-1C87F910-1A0B-4A6B-8481-ADA30FC5702AQ21198960-0C967D46-4A59-4C5B-A32D-6761A9EAD2F6Q21198978-93F42636-7F91-4FF0-919D-06CFB897C934Q21209199-36D26991-AFC7-4914-807E-FBD07F3624ACQ21209296-C0B55776-AB2F-4D20-BD71-55D5C4A7E3B0
P279
Q1147372-5163F666-B3CB-46EB-A917-CAA1B48335F1Q11913806-2BF3549D-CEB9-4778-B976-EBDA22A66045Q141591-CCE4BDD3-1992-4E6F-8D3D-91D0479A665DQ14863086-00F871E5-3C38-4E98-94B8-27840A899DA9Q14863366-116E4695-1312-4FA5-89A6-82F93C53F88BQ14865386-621106CB-74EF-484D-A7D7-DFEC2E326409Q14872812-BBD56E54-95B9-4991-905A-7A026DCB4A39Q14874000-9420F93E-8CC3-40AA-81D5-D47F2D654DA4Q14874000-983466B1-74F0-4E92-8BDA-EEECFA52765DQ14876092-8B87D88C-227C-4696-8A1A-7C963F28D4BEQ14877504-196BD3B6-4759-495F-96BA-7748652D2D42Q14885208-230789A1-CE13-4666-AF5D-AB9207144192Q14887711-E1B713B5-E3AF-4326-84C7-485D677DAF1AQ14887753-88C9107F-0E04-496C-B813-9B8FD8E2F299Q14901156-39C88B4C-AC34-437F-8F1F-F97875C3ACBCQ14901163-BCDEFEA8-B54B-46E4-8C06-61648D8676E0Q14901301-6E8F080F-68B1-480C-A0B4-4806EA5969D6Q14901460-79A24F1B-5E98-4FFD-8A11-E69FC939695EQ14903577-8DAE5C91-A568-44EE-8F68-284731652AB9Q14904969-FD21C153-F841-40C2-8F5A-1480A80D13F8Q14905099-CB34AD59-7502-45A3-97BC-1B7760E2229FQ14905110-B6690414-124C-48A5-88D5-DFE5DF2CFAE3Q14905144-3B30D5E3-6812-4455-8F55-3E5CB7A75312Q14905173-FFEEB2C9-9EFB-4625-93E0-DCC914DC842DQ14905181-4008D996-F899-4A33-97C8-858588BACDB3Q14906022-7B745E8B-816F-41DC-8A01-927F39344B8FQ14906044-0B7B9321-AEF4-4A04-9D1C-0FC618B27CE3Q14906052-9010F361-52D1-4715-B7EE-535194574311Q14906673-0CD06563-7B99-4E3A-BB04-356B188D5BC8Q14907114-0279EB17-B7E1-424C-9A37-B90655725E07Q14907340-00FA1270-BAFA-4510-936A-6B2374A96648Q14907956-9EE4F67C-CADB-42F7-AC49-48BA3A39412AQ14911575-4471309E-AF50-41DF-8320-4CCD95035D26Q14911588-DC538C02-2E68-407E-A700-38AF74749FA5Q14911646-12361629-2D02-4B2C-B0AC-112F2FC989B6Q14911667-F17145CE-9372-4C38-9C45-89BD03B3AA9EQ14911733-59DB6CC5-86A3-48E7-90CB-DD3D41235AE0Q14911756-1379AB33-4C3B-46E4-9D4E-1514F05F0A19Q14911764-65544F04-9304-4DA4-9635-721009193C20Q14911918-8934FE38-8FD0-4D1C-BAB3-6E4278B4FC09
P680
Q21092404-977DE01C-7BDC-45F6-9B83-568710DCECF4Q24298277-8FCA8D74-5EC1-44B1-93D7-BFF01F5146D6Q24299939-DB214CAF-3482-4343-9157-A40885C10440Q24301730-57A84B52-2AD8-4970-87E2-482DAE6DB244Q24303656-2B03B0E1-E88A-4759-A330-BE32B794219AQ24319671-D194E40A-4455-46B7-9C3D-AAE8DF1D9C6CQ24321732-3E691F1D-8A0B-4F8B-86C7-68F1D9674A61Q24324702-0AF081E4-7168-4950-B84F-4275B5B8957EQ24328753-8DF202CA-110E-4EB2-B169-65BF6E31F122Q28118025-5568CFA5-26F1-4EFE-82CA-DC61B5A59A92Q39679031-A2C76450-4CDB-41C9-A5EB-9E648C119E2DQ39891376-0243C5BF-501E-4AC9-A748-B37F32A72C43Q41757658-E3C4BA41-FE53-44CE-80F8-53711DBD8E79
P921
description
Catalysis of the transfer of a ...... ATP, to a substrate molecule.
@en
Katalyse des Transfers einer Phosphatgruppe, normalerweise ATP, auf ein Substratmolekül.
@de
biologisch proces
@nl
name
Kinaseaktivität
@de
activité kinase
@fr
aktiveco de kinazo
@eo
kinase activity
@en
kinaseaktivitet
@nn
type
label
Kinaseaktivität
@de
activité kinase
@fr
aktiveco de kinazo
@eo
kinase activity
@en
kinaseaktivitet
@nn
altLabel
GO:0016301
@en
GO:0016301
@nn
Phosphokinaseaktivität
@de
activité kinasique
@fr
phosphokinase activity
@en
prefLabel
Kinaseaktivität
@de
activité kinase
@fr
aktiveco de kinazo
@eo
kinase activity
@en
kinaseaktivitet
@nn
P2888
P361
P686
GO:0016301